On October 3, 2025, a multicenter team from Shenzhen University, Xiangya Hospital of Central South University, Zhujiang Hospital of Southern Medical University, Wuxi People's Hospital Affiliated to ...

On October 3, 2025, a multicenter team from Shenzhen University, Xiangya Hospital of Central South University, Zhujiang Hospital of Southern Medical ...

Results Underscore PRP Candidacy as a Disruptor of the Tumor MicroenvironmentMELBOURNE, Australia, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”) ...

CD8⁺ T cells are central effectors of antitumor immunity, capable of recognizing and eliminating malignant cells. Their presence within tumors often ...

The higher the deduction, the lower the payout ratio in insurance claims, which often leads the family to bear significant ...

Corinne Van Hoven, a senior honors medical diagnostics major, spent the summer conducting cancer research at Fox Chase Cancer ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years. One of the factors contributing to its aggressiveness is its tumor ...

Bezuclastinib plus sunitinib achieved significant efficacy in imatinib-resistant GIST, with a median progression-free survival of 16.5 months versus 9.2 months for sunitinib alone. The combination ...

GISTs originate from interstitial cells of Cajal and are staged by size, location, mitotic rate, and genetic mutations, influencing treatment strategies. Diagnosis involves imaging, endoscopy, biopsy, ...

Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun. Gastrointestinal stromal tumor (GIST) is a rare type of ...

The diagnosis of sex cord-stromal tumors is challenging. They show a wide spectrum of behaviours and associations with clinically important pathogenic germ line variants. In view of recent advances in ...